Muscle Position and Dry Needling Efficacy

June 1, 2026 updated by: Prof. Dr. Daniel Pecos Martín, University of Alcala

The Importance of Muscle Position in the Effectiveness of Dry Needling Technique

Currently, no previous studies have investigated how the position of a muscle before dry needling may influence the outcome and effectiveness of the treatment.

This study aims to demonstrate whether the position of the upper trapezius muscle during dry needling treatment influences the outcome of that treatment in subjects with neck pain.

A total of 46 participants with chronic neck pain will be recruited and randomly assigned to two groups: a dry needling group with the muscle in a stretched position and a dry needling group with the muscle in a shortened position. A total of two treatment sessions will be performed, separated by a 7-day interval. The primary outcome measure will be the intensity of neck and head pain, measured using the visual analog scale (VAS). Other variables to be measured include the cervical disability index, kinesiophobia, and catastrophizing (using a self-completion questionnaire), as well as participants' expectations and post-needling pain.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Madrid
      • Alcalá de Henares, Madrid, Spain, 28805
        • Physioterapy and Pain center research
      • Alcalá de Henares, Madrid, Spain, 2805
        • Clinical University Physiotherapy and pain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18 and 65 years
  • Neck pain lasting more than 3 months
  • Current neck pain greater than 3/10 on the VAS (Visual Analog Scale)
  • Presence of active trigger points in the upper trapezius muscle, meeting the following criteria: Painful point within a taut band whose palpation reproduces the patient's symptoms.

Exclusion Criteria:

  • Neck pain with a medical diagnosis (fractures, arthritis, fibromyalgia, etc.)
  • Radicular pain (paresthesia, burning, electric shocks)
  • Whiplash or any recent trauma
  • Previous surgery
  • Treatment by another physiotherapist within the last 3 months
  • Infections
  • Needle phobia
  • Use of anticoagulant medications
  • Pregnancy
  • Fibromyalgia
  • Metal allergies
  • Cognitive deficits or communication problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Upper trapezius dry needling with adduction shoulder

The dry needling technique will be applied to the trapezius muscle while the subject lies prone, with the upper limb at the side of the body, shoulder lowered, in adduction and cervical region in a neutral position.

The dry needling technique will be applied using a pincer grasp, inserting the needle from the posterior to the anterior portion of the upper trapezius muscle.

Ten incisions will be made in a posteroanterior direction while the patient lies prone and the muscle is grasped with a pincer grip between the first three fingers. The technique will be applied to the area that is mechanically most hyperalgesic and related to the reproduction of the patient's pain.
Experimental: Upper trapezius dry needling with 90º abduction shoulder

The dry needling technique will be applied to the trapezius muscle while the subject lies prone, with the upper limb separated from the body, shoulder at 90 degrees of abduction and cervical region in a neutral position.

The dry needling technique will be applied using a pincer grasp, inserting the needle from the posterior to the anterior portion of the upper trapezius muscle.

Ten incisions will be made in a posteroanterior direction while the patient lies prone and the muscle is grasped with a pincer grip between the first three fingers. The technique will be applied to the area that is mechanically most hyperalgesic and related to the reproduction of the patient's pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The visual analog scale (VAS)
Time Frame: Change from baseline at 3 months
Intensity of neck and head pain: This was measured using the visual analog scale (VAS). It consists of a 10 cm horizontal line, where 0 cm on the left side represents "no pain" and 10 cm on the right side represents "maximum pain." The subject marks a perpendicular line at the point they consider to represent their pain intensity. The examiner then places a millimeter ruler on the scale, assigning a numerical value to the line drawn by the patient. The VAS has proven to be a valid and reliable tool (intraclass correlation coefficient [ICC] 0.71-0.99).
Change from baseline at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability Associated with Neck Pain
Time Frame: Change from baseline at 3 months
The degree of disability associated with neck pain will be measured using the Neck Disability Index (NDI) questionnaire in its Spanish version. The NDI is a 10-item questionnaire, and each item is scored on a scale of 0 to 5 points, with a range of 0 to 50 points. The higher the score, the greater the degree of disability. The NDI has proven to be a reliable tool (ICC 0.98).
Change from baseline at 3 months
Kinesiophobia with the Tampa Kinesiophobia Scale (TSK-11)
Time Frame: Change from baseline at 3 months
The Tampa Kinesiophobia Scale (TSK-11) short version will be used to assess fear of movement. It is an 11-item scale rated on a four-point scale ranging from "strongly agree" to "strongly disagree." Scores range from 11 to 44, with higher scores indicating greater fear of movement and/or (re)injury. This questionnaire has demonstrated similar properties to the original TSK scale, proving to be a valid and reliable instrument.
Change from baseline at 3 months
Catastrophizing with the Pain Catastrophizing Scale (PCS)
Time Frame: Change from baseline at 3 months
Catastrophizing Scale (PCS). The PCS has 13 items scored from 0 to 4 and is composed of three subscales: rumination, magnification, and helplessness. The overall score ranges from 0 to 52. Higher scores indicate a greater degree of pain catastrophizing. A total score >30 represents a clinically significant level of pain catastrophizing. This questionnaire has been shown to be reliable (ICC 0.94).
Change from baseline at 3 months
Local twitch response (LTRs)
Time Frame: Change from baseline at 3 months
Local twitch response (LTRs). The LTRs produced by needle insertion during dry needling will be counted. LTRs are generally associated with better treatment outcomes. A higher number of LTRs indicates better results, and a lower number of LTRs indicates worse results.
Change from baseline at 3 months
Cervical joint Range
Time Frame: Change from baseline mobility at one week after intervention
Flexion, inclination, extension and rotational movement ranges will be measured with a cervical goniometer
Change from baseline mobility at one week after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

December 15, 2026

Study Registration Dates

First Submitted

June 1, 2026

First Submitted That Met QC Criteria

June 1, 2026

First Posted (Actual)

June 5, 2026

Study Record Updates

Last Update Posted (Actual)

June 5, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Pain

Clinical Trials on Dry needling technique with the shoulder in full adduction.

Subscribe